Compare Novavax Inc (NVAX) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while iShares 0 3 Month Treasury Bond ETF trades at $100.59. The key difference: iShares 0 3 Month Treasury Bond ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SGOV | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Fixed Income |
52-Week High | $11.19 | $100.74 |
52-Week Low | $6.22 | $100.28 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
